Literature DB >> 17686569

Breast tumor size assessment: comparison of conventional ultrasound and contrast-enhanced ultrasound.

Yu-Xin Jiang1, He Liu, Ji-Bin Liu, Qing-Li Zhu, Qiang Sun, Xiao-Yan Chang.   

Abstract

Accurate assessment of tumor size is necessary when selecting patients for breast-conserving surgery. In the study of breast contrast-enhanced ultrasound (CEUS), we found that tumor size discrepancy between CEUS and conventional ultrasound (US) existed in some breast lesions, for which the reasons are not clear. Breast CEUS examinations were performed in 104 patients with breast lesions. The measurement of the 104 breast tumors on conventional US was obtained and compared with the measurement on CEUS. A difference in measuring tumor size of >3 mm for tumors up to 1.7 cm and 4 mm for tumors >or=1.7 cm, was defined as a significant discrepancy between conventional US and CEUS. The histopathological examination of size discrepancy was performed and the margin characteristics of breast cancers with larger measurements were compared with those with unchanged measurements. Among the 104 lesions (43 malignant, 60 benign, 1 borderline), the size of 27 breast cancers and one granulomatous mastitis appeared larger at CEUS. Pathologic examinations of the region corresponding to the measurement discrepancy were mainly ductal carcinomas in situ (DCIS), invasive carcinoma with a DCIS component, adenosis with lobular hyperplasia in breast cancers and inflammatory cell infiltration in one granulomatous mastitis. Well-defined margin characteristics were significantly different between breast cancers with larger measurements at CEUS and those with unchanged measurements of size (p = 0.002), whereas no significant difference was found between the two groups in ill-defined, spiculated, hyperechoic halo, microlobulated and angulated margins (p = 0.463, 0.117, 0.194, 0.666 and 0.780, respectively). This initial study suggests that significant discrepancy of breast lesion measurement between conventional US and CEUS is more likely presented in breast cancer than benign lesions. The pathologic findings corresponding to the region of size increased at CEUS are malignant in most malignant lesions and benign in benign lesions. It is difficult to predict whether the size measurement of the breast cancer increases at CEUS based on the margin characteristics showed on conventional US.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686569     DOI: 10.1016/j.ultrasmedbio.2007.06.002

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  18 in total

1.  Contrast-enhanced ultrasound: The evolving applications.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2009-12-31

2.  Role of multi-mode ultrasound in the diagnosis of level 4 BI-RADS breast lesions and Logistic regression model.

Authors:  Xiaoling Leng; Guofu Huang; Lanhui Yao; Fucheng Ma
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Impact of parametric imaging on contrast-enhanced ultrasound of breast cancer.

Authors:  Aya Noro; Takashi Nakamura; Toshiko Hirai; Masayo Haga; Toyoki Kobayashi; Akinobu Hayashi; Yuji Kozuka; Tokiko Nakai; Toru Ogura; Tomoko Ogawa
Journal:  J Med Ultrason (2001)       Date:  2016-01-22       Impact factor: 1.314

Review 4.  The current status of contrast-enhanced ultrasound in China.

Authors:  Hui-Xiong Xu; Ming-De Lu
Journal:  J Med Ultrason (2001)       Date:  2010-04-21       Impact factor: 1.314

5.  Tumor size of breast invasive ductal cancer measured with contrast-enhanced ultrasound predicts regional lymph node metastasis and N stage.

Authors:  Zhiyuan Wang; Qichang Zhou; Jun Liu; Shichu Tang; Xia Liang; Zhengyu Zhou; Ying He; Hui Peng; Yuanming Xiao
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

6.  Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.

Authors:  Xiaoyun Xiao; Qiongchao Jiang; Huan Wu; Xiaofeng Guan; Wei Qin; Baoming Luo
Journal:  Eur Radiol       Date:  2016-10-19       Impact factor: 5.315

7.  Predictive model for contrast-enhanced ultrasound of the breast: Is it feasible in malignant risk assessment of breast imaging reporting and data system 4 lesions?

Authors:  Jun Luo; Ji-Dong Chen; Qing Chen; Lin-Xian Yue; Guo Zhou; Cheng Lan; Yi Li; Chi-Hua Wu; Jing-Qiao Lu
Journal:  World J Radiol       Date:  2016-06-28

Review 8.  Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review.

Authors:  Rongrong Guo; Guolan Lu; Binjie Qin; Baowei Fei
Journal:  Ultrasound Med Biol       Date:  2017-10-26       Impact factor: 2.998

9.  Homogeneously enhancing breast lesions on contrast enhanced US: differential diagnosis by conventional and contrast enhanced US findings.

Authors:  Ritsuko Fujimitsu; Mikiko Shimakura; Hiroshi Urakawa; Ayako Morita; Yoshinobu Shinagawa; Keiko Sakamoto; Kengo Yoshimitsu
Journal:  Jpn J Radiol       Date:  2016-05-03       Impact factor: 2.374

10.  Diagnostic value of contrast-enhanced ultrasound parametric imaging in breast tumors.

Authors:  Zhang Yuan; Jiang Quan; Zhang Yunxiao; Chen Jian; He Zhu; Gong Liping
Journal:  J Breast Cancer       Date:  2013-06-28       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.